MANDALA Asthma Study

Trial Objective

MANDALA Asthma StudyMANDALA is a research study that will look at the safety and efficacy of the investigational drug in comparison to an existing treatment to relieve symptoms in children and adults with moderate to severe asthma. Two doses of budesonide and albuterol inhalation suspension (BDA MDI) is compared to an albuterol metered dose inhaler (albuterol MDI). Safety and efficacy of BDA MDI is compared with albuterol MDI to relieve symptoms in children ages 4 and older and adults with moderate to severe asthma.

Enrollment

New enrollment for this trial is temporarily paused

Who Can Participate

Children ages 4 and older and adults who have been diagnosed with asthma for at least 1 year, who are on daily asthma inhalers and have had at least 1 asthma flare in the last 12 months.

Age: 4+    Gender: Any Gender


Estimated Time Commitment

After screening, treatment will last from 24 to 36 weeks



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Allen Stevens

Allen Stevens
303.398.1443

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Bond Avillion 2

Principal Investigators

Co-Investigators


Request More Information

After limiting clinical research activity due to safety concerns about COVID-19, we are now restarting clinical research in stages. If you are interested in any of the clinical trials posted on our website, please request trial information. We will respond and share the timing for enrollment resuming. Learn More


*
*
*
*